Cargando…
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma
Current cutaneous T-cell lymphoma (CTCL) therapies are marked by an abbreviated response, subsequent drug resistance, and poor prognosis for patients with advanced disease. An understanding of molecular regulators involved in CTCL is needed to develop effective targeted therapies. One candidate regu...
Autores principales: | Zhang, Xu Hannah, Nam, Sangkil, Wu, Jun, Chen, Chih-Hong, Liu, Xuxiang, Li, Hongzhi, McKeithan, Timothy, Gong, Qiang, Chan, Wing C., Yin, Hongwei Holly, Yuan, Yate-Ching, Pillai, Raju, Querfeld, Christiane, Horne, David, Chen, Yuan, Rosen, Steven T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269016/ https://www.ncbi.nlm.nih.gov/pubmed/29758280 http://dx.doi.org/10.1016/j.jid.2018.04.030 |
Ejemplares similares
-
Targeting the non‐ATP‐binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T‐cell lymphoma (CTCL)
por: Zhang, Xu Hannah, et al.
Publicado: (2021) -
Multiple forms of tubulin in the cytoskeletal and flagellar microtubules of polytomella
por: McKeithan, TW, et al.
Publicado: (1981) -
Reprogramming of PD-1(+) M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma
por: Han, Zhen, et al.
Publicado: (2023) -
DNMT1 and p38γ are inversely expressed in reactive non‐metastatic lymph nodes burdened with colorectal adenocarcinoma
por: Zhang, Xu Hannah, et al.
Publicado: (2020) -
Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1
por: Dong, Gehong, et al.
Publicado: (2020)